Cobb SR, Buhl EH, Halasy K, Paulsen O, Somogyi P: Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature. 1995, 378: 75-78. 10.1038/378075a0.
Article
CAS
PubMed
Google Scholar
Saiz A, Blanco Y, Sabater L, Gonzalez F, Bataller L, Casamitjana R, Ramio-Torrenta L, Graus F: Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain. 2008, 131: 2553-2563. 10.1093/brain/awn183.
Article
PubMed
Google Scholar
Ali F, Rowley M, Jayakrishnan B, Teuber S, Gershwin ME, Mackay IR: Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies. J Autoimmun. 2011, 37: 79-87. 10.1016/j.jaut.2011.05.005.
Article
CAS
PubMed
Google Scholar
Thivolet CH, Tappaz M, Durand A, Petersen J, Stefanutti A, Chatelain P, Vialettes B, Scherbaum W, Orgiazzi J: Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals. Diabetologia. 1992, 35: 570-576. 10.1007/BF00400486.
Article
CAS
PubMed
Google Scholar
Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA: Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med. 1994, 11: 299-303. 10.1111/j.1464-5491.1994.tb00275.x.
Article
CAS
PubMed
Google Scholar
Knip M, Siljander H: Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev. 2008, 7: 550-557. 10.1016/j.autrev.2008.04.008.
Article
CAS
PubMed
Google Scholar
Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011, 34 (Suppl 1): S62-S69.
Landin-Olsson M: Latent autoimmune diabetes in adults. Ann N Y Acad Sci. 2002, 958: 112-116.
Article
PubMed
Google Scholar
Cukierman-Yaffe T, Gerstein HC, Williamson JD, Lazar RM, Lovato L, Miller ME, Coker LH, Murray A, Sullivan MD, Marcovina SM, Launer LJ: Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care. 2009, 32: 221-226.
Article
PubMed
PubMed Central
Google Scholar
Jacobson AM, Ryan CM, Cleary PA, Waberski BH, Weinger K, Musen G, Dahms W: Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort. Diabetologia. 2011, 54: 245-255. 10.1007/s00125-010-1883-9.
Article
CAS
PubMed
Google Scholar
Luchsinger JA: Diabetes, related conditions, and dementia. J Neurol Sci. 2010, 299: 35-38. 10.1016/j.jns.2010.08.063.
Article
PubMed
PubMed Central
Google Scholar
Bhat NR: Linking cardiometabolic disorders to sporadic Alzheimer's disease: a perspective on potential mechanisms and mediators. J Neurochem. 2010, 115: 551-562. 10.1111/j.1471-4159.2010.06978.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Carlsson CM: Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease. J Alzheimers Dis. 2010, 20: 711-722.
PubMed
PubMed Central
Google Scholar
Takagi M, Yamasaki H, Endo K, Yamada T, Kaneko K, Oka Y, Mori E: Cognitive Decline in a Patient with Anti-glutamic Acid Decarboxylase Autoimmunity; Case Report. BMC Neurol. 2011, 11: 156-10.1186/1471-2377-11-156.
Article
CAS
PubMed
PubMed Central
Google Scholar
Langan SJ, Deary IJ, Hepburn DA, Frier BM: Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Diabetologia. 1991, 34: 337-344. 10.1007/BF00405006.
Article
CAS
PubMed
Google Scholar
Ohta M, Obayashi H, Takahashi K, Kitagawa Y, Nakano K, Matsuo S, Nishimura M, Itoh N, Ohta K: Radioimmunoprecipitation assay for glutamic acid decarboxylase antibodies evaluated clinically with sera from patients with insulin-dependent diabetes mellitus. Clin Chem. 1996, 42: 1975-1978.
CAS
PubMed
Google Scholar
Folstein MF, Folstein SE, McHugh PR: "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975, 12: 189-198. 10.1016/0022-3956(75)90026-6.
Article
CAS
PubMed
Google Scholar
Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, Lopez OL, DeKosky ST: Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000, 12: 233-239. 10.1176/appi.neuropsych.12.2.233.
Article
CAS
PubMed
Google Scholar
Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM: Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003, 348: 1215-1222. 10.1056/NEJMoa022066.
Article
PubMed
Google Scholar
Scheltens P, Barkhof F, Leys D, Pruvo JP, Nauta JJ, Vermersch P, Steinling M, Valk J: A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci. 1993, 114: 7-12. 10.1016/0022-510X(93)90041-V.
Article
CAS
PubMed
Google Scholar
Ashburner J: A fast diffeomorphic image registration algorithm. Neuroimage. 2007, 38: 95-113. 10.1016/j.neuroimage.2007.07.007.
Article
PubMed
Google Scholar
Bourdel-Marchasson I, Lapre E, Laksir H, Puget E: Insulin resistance, diabetes and cognitive function: consequences for preventative strategies. Diabetes Metab. 2010, 36: 173-181. 10.1016/j.diabet.2010.03.001.
Article
CAS
PubMed
Google Scholar
Berk-Planken I, de Konig I, Stolk R, Jansen H, Hoogerbrugge N: Atorvastatin, diabetic dyslipidemia, and cognitive functioning. Diabetes Care. 2002, 25: 1250-1251. 10.2337/diacare.25.7.1250.
Article
PubMed
Google Scholar
Ferguson SC, Blane A, Perros P, McCrimmon RJ, Best JJK, Wardlaw J, Deary IJ, Frier BM: Cognitive Ability and Brain Structure in Type 1 Diabetes. Diabetes. 2003, 52: 149-10.2337/diabetes.52.1.149.
Article
CAS
PubMed
Google Scholar
Frier BM: Hypoglycaemia and cognitive function in diabetes. Int J Clin Pract Suppl. 2001, 123: 30-37.
PubMed
Google Scholar
Elias M, Elias P, Sullivan L, Wolf P, D'Agostino R: Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. International Journal of Obesity. 2003, 27: 260-268. 10.1038/sj.ijo.802225.
Article
CAS
PubMed
Google Scholar
Knopman DS, Roberts R: Vascular risk factors: imaging and neuropathologic correlates. J Alzheimers Dis. 2010, 20: 699-709.
PubMed
PubMed Central
Google Scholar
Manschot SM, Brands AM, van der Grond J, Kessels RP, Algra A, Kappelle LJ, Biessels GJ: Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes. 2006, 55: 1106-1113. 10.2337/diabetes.55.04.06.db05-1323.
Article
CAS
PubMed
Google Scholar
Arnold DB, Robinson DA, Leigh RJ: Nystagmus induced by pharmacological inactivation of the brainstem ocular motor integrator in monkey. Vision Res. 1999, 39: 4286-4295. 10.1016/S0042-6989(99)00142-X.
Article
CAS
PubMed
Google Scholar
Oskarsson B, Pelak V, Quan D, Hall D, Foster C, Galetta S: Stiff eyes in stiff-person syndrome. Neurology. 2008, 71: 378-380. 10.1212/01.wnl.0000319725.22925.b4.
Article
CAS
PubMed
Google Scholar
Heinrichs RW, Zakzanis KK: Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998, 12: 426-445.
Article
CAS
PubMed
Google Scholar
Lewis DA, Volk DW, Hashimoto T: Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology. 2004, 174: 143-150.
Article
CAS
PubMed
Google Scholar
Guidotti A, Auta J, Davis JM, Dong E, Grayson DR, Veldic M, Zhang X, Costa E: GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology (Berl). 2005, 180: 191-205. 10.1007/s00213-005-2212-8.
Article
CAS
Google Scholar
Fatemi SH, Stary JM, Earle JA, Araghi-Niknam M, Eagan E: GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum. Schizophr Res. 2005, 72: 109-122. 10.1016/j.schres.2004.02.017.
Article
PubMed
Google Scholar
Somogyi P, Klausberger T: Defined types of cortical interneurone structure space and spike timing in the hippocampus. J Physiol. 2005, 562: 9-26.
Article
CAS
PubMed
Google Scholar
Saidha S, Murphy S, Ronayne A, McCarthy P, Hennessy MJ, Counihan T: Treatment of anti-glutamic acid decarboxylase antibody-associated limbic encephalitis with mycophenolate mofetil. J Neurol. 2010, 257: 1035-1038. 10.1007/s00415-010-5476-9.
Article
PubMed
Google Scholar
Dalakas MC, Fujii M, Li M, Lutfi B, Kyhos J, McElroy B: High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med. 2001, 345: 1870-1876. 10.1056/NEJMoa01167.
Article
CAS
PubMed
Google Scholar